Baxter amps up cancer drug contract manufacturing; Aesica teams up with Britest;

> Boehringer Ingelheim has tapped Hungary's ChemAxon and its R&D software to help usher compounds from discovery to the clinic. News

> Takeda plans to lend a helping hand to CMO Nihon Pharmaceuticals as the company grapples with ire from Japanese regulators. Story

> Aesica has partnered with Britest to expand its API-production know-how. Article

> Jamaican CMO Benjamin Manufacturing is getting an earful from the FDA over sterility and quality control. More

> Baxter ($BAX) is responding to the boom in targeted cancer drugs by beefing up its CMO unit's cytotoxic manufacturing capabilities. Report